Meddo, an Indian startup working a digital outpatient care platform, has bought Doxper, one other startup, by way of a money and inventory deal.
WHAT THEY DO
Based in 2015, Doxper supplies a platform for well being document administration and affected person engagement. Its AI-powered digital pen and paper answer permits docs to immediately digitise case sheets with none change in behaviour or workflow. Additionally it is used to automate reminders for streamlining affected person remedy plans. The corporate claims to serve greater than 4,000 docs, in addition to 1,800 clinics and 50 hospitals, corresponding to Cloudnine, Manipal Hospitals and BLK Max.
Meddo, however, transforms clinics into full-service well being centres via its digitally enabled companies. Since 2018, it has served over 10 million sufferers and delivered greater than 15 million digitised prescriptions. Presently, it operates round 250 good clinics in Delhi and Bangalore.
WHY IT MATTERS
Based mostly on a press assertion, Doxper’s acquisition will convey round 300,000-400,000 extra sufferers monthly to Meddo’s buyer base, making the digital outpatient care platform one of many largest well being tech gamers in India. With Doxper, it additionally eyes to remodel 1,000 extra clinics inside the subsequent 12-15 months throughout 10 top-tier markets in India.
THE LARGER TREND
Doxper is at present increasing internationally with an enormous rollout in about 1,000 clinics in Bangladesh and a pilot in two maternity care centres in Nigeria.
In the course of the pandemic, Meddo launched numerous options, together with L1 COVID-19 centres, teleconsultation companies, diagnostic options and a healthcare membership programme referred to as MeddoSure.
ON THE RECORD
“Enabling Meddo’s one-stop look after thousands and thousands of sufferers throughout the Doxper community, along with their prescription expertise, creates the correct ecosystem to essentially rework outpatient care, which has been our purpose from the get-go,” Meddo Founder and CEO Saurabh Kochhar mentioned.
“We actually imagine in Meddo’s omnichannel fulfilment-led strategy and are excited to hitch this transformative journey. We’re assured that our integration will improve and enhance scientific outcomes for clinicians and sufferers,” Doxper Co-founder and CEO Shailesh Prithani additionally acknowledged.